{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tetanus+toxoid", "query": { "intervention": "Tetanus toxoid" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 189, "total_pages": 19, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Tetanus+toxoid&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-13T15:22:29.832Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01311557", "title": "Study of Adacel® Vaccine Administered to Persons 10 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Tetanus", "Diphtheria", "Pertussis" ], "interventions": [ { "name": "Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "10 Years to 11 Years" }, "enrollment_count": 1302, "start_date": "2011-03", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 34, "location_summary": "Chandler, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 31 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Sacramento", "state": "California" }, { "city": "Longmont", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01311557" }, { "nct_id": "NCT01738477", "title": "Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Tetanus", "Acellular Pertussis", "Diphtheria" ], "interventions": [ { "name": "Boostrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "19 Years to 30 Years" }, "enrollment_count": 165, "start_date": "2013-01-31", "completion_date": "2014-04-02", "has_results": true, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 20, "location_summary": "Mesa, Arizona • Tempe, Arizona • Jonesboro, Arkansas + 16 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fullerton", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01738477" }, { "nct_id": "NCT07160244", "title": "BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Multivalent Group B streptococcus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "Infanrix hexa", "type": "BIOLOGICAL" }, { "name": "Prevenar 20", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Prevnar 20", "type": "BIOLOGICAL" }, { "name": "Infanrix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Day", "maximum_age": "49 Years", "sex": "ALL", "summary": "1 Day to 49 Years" }, "enrollment_count": 6000, "start_date": "2025-08-25", "completion_date": "2029-03-02", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 119, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 57 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07160244" }, { "nct_id": "NCT01544764", "title": "Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adolescent Health Services", "Immunization" ], "interventions": [ { "name": "Assessment , Feedback, Incentives, and eXchange Program", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 91, "start_date": "2011-04", "completion_date": "2012-12", "has_results": false, "last_update_posted_date": "2013-12-18", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 2, "location_summary": "Chapel Hill, North Carolina • Raleigh, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01544764" }, { "nct_id": "NCT01846143", "title": "Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma" ], "interventions": [ { "name": "pBCAR3-phosphopeptide", "type": "BIOLOGICAL" }, { "name": "pIRS2-phosphopeptide", "type": "BIOLOGICAL" }, { "name": "2-MpP (pBCAR3-phosphopeptide + pIRS2-phosphopeptide)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Craig L Slingluff, Jr", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2013-05", "completion_date": "2015-11", "has_results": false, "last_update_posted_date": "2016-08-12", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01846143" }, { "nct_id": "NCT00282308", "title": "A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Methylprednisone", "type": "DRUG" }, { "name": "C. albicans", "type": "BIOLOGICAL" }, { "name": "Tetanus toxoid adsorbed booster vaccine", "type": "BIOLOGICAL" }, { "name": "23-valent pneumococcal polysaccharide vaccine", "type": "BIOLOGICAL" }, { "name": "Keyhole limpet hemocyanin", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 103, "start_date": "2006-01-23", "completion_date": "2012-05-28", "has_results": true, "last_update_posted_date": "2017-08-10", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 34, "location_summary": "Birmingham, Alabama • Paradise Valley, Arizona • Peoria, Arizona + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Palm Desert", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00282308" }, { "nct_id": "NCT04084769", "title": "Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Immunisation (Healthy Volunteers)" ], "interventions": [ { "name": "Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine MenACYW Conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Group B vaccine (Trumenba®)", "type": "BIOLOGICAL" }, { "name": "Meningococcal group B vaccine (Bexsero®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "26 Years", "sex": "ALL", "summary": "13 Years to 26 Years" }, "enrollment_count": 570, "start_date": "2019-09-03", "completion_date": "2020-09-14", "has_results": true, "last_update_posted_date": "2025-09-15", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 29, "location_summary": "Birmingham, Alabama • San Diego, California • Bardstown, Kentucky + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Bridgeton", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT04084769" }, { "nct_id": "NCT00892567", "title": "Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Neoplasms" ], "interventions": [ { "name": "9 Peptides from Her-2/neu, CEA, & CTA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Craig L Slingluff, Jr", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9, "start_date": "2009-05", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00892567" }, { "nct_id": "NCT00109330", "title": "A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diphtheria", "Tetanus", "Acellular Pertussis" ], "interventions": [ { "name": "Combined diphtheria, tetanus, acellular pertussis vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 4116, "start_date": "2002-11", "completion_date": "2004-04", "has_results": false, "last_update_posted_date": "2016-09-09", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 44, "location_summary": "Mesa, Arizona • Tempe, Arizona • Jonesboro, Arkansas + 39 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00109330" }, { "nct_id": "NCT00008853", "title": "Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Bacterial Infections", "Group B Streptococcus" ], "interventions": [ { "name": "GBS III-TT-SSI", "type": "BIOLOGICAL" }, { "name": "GBS III-TT-MPHL", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 65, "start_date": null, "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2010-08-27", "last_synced_at": "2026-09-13T15:22:29.832Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00008853" } ] }